Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 11, 2006 - Issue 4
Submit an article Journal homepage
207
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Bioavailability Enhancement of Poorly Water Soluble and Weakly Acidic New Chemical Entity with 2-Hydroxy Propyl-β-Cyclodextrin: Selection of Meglumine, a Polyhydroxy Base, as a Novel Ternary Component

S. Basavaraj Formulation Research Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
Vaibhav Sihorkar Formulation Research Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
T.R. Shantha Kumar Formulation Research Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
Prakash Sundaramurthi Formulation Research Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
Nuggehally R. Srinivas Formulation Research Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India; Drug Metabolism and Pharmacokinetic Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India; Drug Development, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
P. Venkatesh Drug Metabolism and Pharmacokinetic Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
,
Mullangi Ramesh Drug Metabolism and Pharmacokinetic Department, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
&
Sunil Kumar Singh Medicinal Chemistry, Discovery Research, Dr. Reddy's Laboratories Ltd., Hyderabad, India
 show all
Pages 443-451 | Received 03 Oct 2005, Accepted 07 Jan 2006, Published online: 07 Oct 2008

REFERENCES

  • Gallop M.A., Barrett R.W., Dower W.J., Fodor S.P., Gordon E.M. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. J. Med. Chem 1994; 37(9)1233–1251, [INFOTRIEVE], [CSA]
  • Gordon E.M., Barrett R.W., Dower W.J., Fodor S.P., Gallop M.A. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, libraries screening strategies and future directions. J. Med. Chem 1994; 37(10)1385–1401, [INFOTRIEVE], [CSA], [CROSSREF]
  • Prentis R.A., Lis Y., Walker S.R. Pharmaceutical innovation by the seven UK owned pharmaceutical companies (1964–1985). Br. J. Clin. Pharmacol 1988; 25(3)387–396, [INFOTRIEVE], [CSA]
  • Shanthakumar T.R., Sundaramurthi P., Basavaraj, Ramesh M., Venkatesh P., Ravi K., Vaidyanathan G., Kumar R., Kumar P., Rao K., Singh S.K. Comparative PK profile of DRF- 4367 nanosuspension & HPβCD complex. Fifth International Symposium on Advances in Tech. & Business Potential of NDDS, MumbaiINDIA, Feb, 16–17, 2004
  • Ramesh M., Mamidi Rao N.V.S., Jagannath K., Singh S.K., Srinivasa Rao K., Rajagopalan R., Srinivas N.R. Oral bioavailability and pharmacokinetics of DRF-4367, a new cox-2 inhibitor in rats. Eur. J. Drug Metab. Pharmacokinet 2003; 28(2)137–141, [INFOTRIEVE], [CSA]
  • Bekers O., Uijtendaal E.V., Beijnen J.H., Bult A., Underberg W.J. Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm 1991; 17: 1503–1549, [CSA]
  • Szente L., Szentli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug. Del. Rev 1999; 36(1)17–28, [CSA], [CROSSREF]
  • 8. Loftsson, T. Cyclodextrins in pharmaceutical formulations: A report prepared for Nordic Industrial Fund, 1998
  • Mura P., Maestrelli F., Cirii M. Ternary systems of naproxen with hydroxy propyl-beta-cyclodextrin and amino acids. Int. J. Pharm 2003; 260: 293–302, [INFOTRIEVE], [CSA], [CROSSREF]
  • Blanchard J., Ugwu S. O., Bhardwaj R., Dorr R.T. Development and testing of an improved parenteral formulation of phenytoin using 2-hydroxypropyl-β-cyclodextrin. Pharm. Dev. Tech 2000; 5(3)333–338, [CSA], [CROSSREF]
  • Peeters J., Neeskens P., Tollenaere J.P., Remoortere P., Brewster M.E. Characterizion of the interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4, and 7. J. Pharm. Sci 2002; 91(6)1414–1422, [INFOTRIEVE], [CSA], [CROSSREF]
  • Yesook, Johnson, Kevin C., Shanker, Ravi M. Inclusion complexes of aryl-heterocyclic salts. US patent No. 6., 2002, 399, 777
  • Mura P., Faucci M.T., Bettenetti G.P. The Influence of poly vinyl pyrrolidone on naproxen complexation with hydroxypropyl–β-cyclodextrin. Eur. J. Pharm 2001; 13(2)187–194, [CSA], [CROSSREF]
  • Valero M., Carrillo C., Rodriguez L.J. Ternary naproxen: β-cyclodextrin: polyethylene glycol complex formation. Int. J. Pharm 2003; 265: 141–149, [INFOTRIEVE], [CSA], [CROSSREF]
  • Higuchi T., Connors K.A. C.N. ReilleyPhase solubility techniques. Advances in Analytical Chemistry and Instrumentation, . Inter science, New York 1965; 4: 117–222
  • Suryanarayanan R. X-ray powder diffractometry. Physical Characterization of Pharmaceutical Solids. Marcel Dekker, Inc., New York 1995; 70: 187–222
  • Krishnamoorthy R., Mitra A.K. Complexation of weak acids and bases with cyclodextrins: Effect of substrates ionization on estimation and interpretation of association constatnt. Int. J. Pharm. Adv 1996; 1: 330–343, [CSA]
  • Tong W.Q., Whitesell G. In situ salt screening—A useful technique for discovery support and preformulation studies. Pharm. Dev. Tech 1998; 3(2)215–223, [CSA]
  • Pose-Vilarnovo B., Perdomo-Lopez I., Echezarreta-Lopez M., Schroth-Pardo P., Estrada E., Torres-Labandeira JJ. Improvement of water solubility of sulfamethizole through its complexation with β- and hydroxypropyl- β-cyclodextrin: Characterization of the interaction in solution and solid state. Eur. J. Pharm. Sci 2001; 13: 325–331, [INFOTRIEVE], [CSA], [CROSSREF]
  • Wong J.W., Yuen K.H. Inclusion complexation of Artemisinin with α-, ß-, and γ-cyclodextrins. Drug Dev. Ind. Pharm 2003; 29(9)1035–1044, [INFOTRIEVE], [CSA], [CROSSREF]
  • Zuo Z., Kwon G., Stevenson B., Diakur J., Wiebe L.I. Flutamide – hydroxy propyl–β-cyclodextrin complexation: Formulation, physical charecterization, and absorption studies using the Caco-2 in vitro model. J. Pharm. Pharm. Sci 2000; 3: 220–227, [INFOTRIEVE], [CSA]
  • Babu M.K., Godiwala T.N. Toward the development of an injectable dosage form of propofol: preparation and evaluation of propofol-sulfobutyl ether 7-beta-cyclodextrin complex. Pharm. Dev. Tech 2004; 9(3)265–275, [CSA], [CROSSREF]
  • Clas S.D., Dalton C.R., Hancock B.C. Differential scanning calorimetry: applications in drug development. Pharm. Sci.Tech. Today 1999; 2: 311–320, [CSA], [CROSSREF]
  • Mamidi Rao N.V.S., Ramesh M., Jagannath K., Ansar A.K., Rajagopalan R., Srinivas N.R. Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats. Biopharm. Drug. Dispos 2002; 23: 273–282, [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.